Bariatric surgery tied to higher weight loss than Wegovy, Zepbound in real-world setting

Bariatric surgery may confer greater long-term weight loss than semaglutide or tirzepatide for adults with obesity, according to data from a real-world study published in Obesity. Karan R. Chhabra, MD, MSc, assistant professor of surgery and population health at NYU Grossman School of Medicine, said prior studies comparing weight loss with GLP-1 receptor agonists to bariatric surgery tend